Edition:
United Kingdom

People: Eagle Pharmaceuticals Inc (EGRX.OQ)

EGRX.OQ on NASDAQ Stock Exchange Global Market

55.92USD
23 Aug 2019
Change (% chg)

$-2.30 (-3.95%)
Prev Close
$58.22
Open
$58.42
Day's High
$58.49
Day's Low
$55.64
Volume
60,055
Avg. Vol
67,775
52-wk High
$82.33
52-wk Low
$36.10

Ratoff, Steven 

Mr. Steven B. Ratoff is Independent Director of Eagle Pharmaceuticals, Inc., since March 2007. Mr. Ratoff has served as the chief executive officer of CM Systems LLC, a cloud based software company, since July 2018. Mr. Ratoff's prior experience includes serving as a venture partner for ProQuest Investments from 2005 to 2013, as chief executive officer of Novadel Pharma, Inc., a specialty pharmaceutical company from 2010 to 2017, and as chief executive officer of CIMA Labs, Inc., a specialty pharmaceutical company acquired by Cephalon in 2004. In addition, Mr. Ratoff served as chief financial officer of the Brown-Forman Company from 1995 to 2001. Mr. Ratoff holds a B.S. in business administration from Boston University and an M.B.A. with Distinction from the University of Michigan. Our Board believes that Mr. Ratoff's extensive executive experience and background in the global pharmaceutical and consumer products industries as well as his strong financial background qualifies him to serve on our Board.

Basic Compensation

Total Annual Compensation, USD 80,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 254,778
Fiscal Year Total, USD 334,778

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Graves

392,278

David Pernock

3,675,440

Scott Tarriff

11,324,500

Pete Meyers

2,673,850

Adrian Hepner

3,134,840

Douglas Braunstein

319,778
As Of  31 Dec 2018